Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-25-008773

President and CEO gave up 27,214 shares (to pay taxes)

  • President and CEO acquired 4,105 shares (grant or award)
  • President and CEO acquired 62,270 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Garg Vipin K · President and CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-30 Exercise or conversion : show line 1 in the form +26,775 342,696 D
2025-01-30 Shares withheld for taxes : show line 2 in the form −11,701 $7.00 $81,907 330,995 D
2025-01-31 Grant or award : show line 3 in the form +4,105 $5.18 $21,264 335,100 D
2025-02-01 Exercise or conversion : show line 4 in the form +16,545 351,645 D
2025-02-01 Shares withheld for taxes : show line 5 in the form −7,231 $6.64 $48,014 344,414 D
2025-02-02 Exercise or conversion : show line 6 in the form +18,950 363,364 D
2025-02-02 Shares withheld for taxes : show line 7 in the form −8,282 $6.64 $54,992 355,082 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-01-30 Exercise or conversion : show line 8 in the form Restricted Stock Units +26,775 53,550 D
2025-02-01 Exercise or conversion : show line 9 in the form Restricted Stock Units +16,545 0 D
2025-02-02 Exercise or conversion : show line 10 in the form Restricted Stock Units +18,950 18,950 D
Loading xslF345X05/tm255357-4_4seq1.xml…